Divis Laboratories

Overview

Divis Laboratories is a pharmaceutical company headquartered in Hyderabad, India, founded in 1990, with over 10,000 employees.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances Divis Laboratories is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Divis Laboratories holds 37 active (55 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• BRIVARACETAMActive2025-03-31
• LOSARTAN POTASSIUM USPActive2024-09-26
• RIVAROXABAN USPActive2024-09-19
• IRBESARTAN USPActive2023-11-07
• TICAGRELORActive2022-01-27
• ORLISTATActive2021-04-30
• LACOSAMIDEActive2021-03-09
• VIGABATRIN USPActive2017-07-29
• PREGABALIN (ALTERNATIVE PROCESS)Active2016-08-01
• LEVETIRACETAM (PROCESS B)Active2016-01-08
• MESALAMINE USPActive2015-11-06
• OLMESARTAN MEDOXOMIL USPActive2014-01-28
• VALSARTAN USPActive2011-03-29
• TRITYL LOSARTANActive2010-09-15
• 2-4-WING ACTIVE ESTERActive2010-07-23

Showing 15 of 55 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Divis Laboratories in our records. PharmaTek screens the full directory against live FDA enforcement data.